NEXTNAV INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NEXTNAV INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.57M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.67M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $3.86M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $3.93M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $763.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $569.0K | Mar 23, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($189.25M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($101.88M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($71.74M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($40.12M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($144.67M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($137.34M) | Mar 23, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($70.23M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($60.10M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($63.53M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($65.54M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($42.43M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($29.47M) | Mar 23, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.95M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $16.24M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $19.50M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $17.06M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $9.47M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $8.78M | Mar 23, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.56M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $33.51M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $30.32M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $36.93M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $13.56M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $13.26M | Mar 23, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($50.75M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($38.01M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($35.44M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($37.10M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($47.93M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($28.41M) | Mar 23, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $350.0K | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $2.75M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.96M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $1.02M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $6.42M | Mar 23, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.02M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $161.74M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $162.16M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $123.79M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $136.82M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $44.90M | Mar 23, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $333.25M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $111.62M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $82.06M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $19.92M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $36.87M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $165.68M | Mar 23, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($86.24M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $50.12M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $78.73M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $100.02M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $99.96M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($490.38M) | Mar 23, 2022 |
| FY2021 | Dec 31, 2019 | ($327.36M) | Mar 23, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.16M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $16.97M | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | $17.98M | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | $17.49M | Mar 12, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.05B) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($862.11M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($760.23M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($688.49M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($647.86M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($490.28M) | Mar 23, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | (6) | Mar 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | (6) | Mar 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 135.37M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 131.14M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 111.13M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 106.42M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 96.55M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 7.35M | Mar 23, 2022 |